CollPlant Biotechnologies Ltd. Banner Image

CollPlant Biotechnologies Ltd.

  • Ticker CLGN
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
CollPlant Biotechnologies Ltd. Logo Image
  • 11-50 Employees
  • Based in Rehovot, Israel
CollPlant is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs, and medical aesthetics. Their products are based on their rhCollagen (recombinant human collagen) that is produced with CollPlant's proprietary plant based genetic engineering technology. Their products address indications for the diverse fields of tissue repair, aesthetics and organMore manufacturing, and, they believe, are ushering in a new era in regenerative and aesthetic medicine. Their flagship rhCollagen BioInk product line is ideal for 3D bioprinting of tissues and organs. In October 2018, they entered into a licensing agreement with United Therapeutics, whereby United Therapeutics is using CollPlant's BioInks in the manufacture of 3D bioprinted lungs for transplant in humans.
4.8 / 5.0 (96)

CollPlant Biotechnologies Ltd. reports have an aggregate usefulness score of 4.8 based on 96 reviews.

CollPlant Biotechnologies Ltd.

Most Recent Annual Report

CollPlant Biotechnologies Ltd.
MOST RECENT 2023 Annual Report

Older/Archived Annual Reports

CollPlant Biotechnologies Ltd. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!